HTB

2006

Prospective follow up of children with lipodystrophy

Tuberculosis in HIV-positive children often missed from incidence data: the influence of HAART on paediatric TB

Nevirapine pharmacokinetics with infant prophylaxis

Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy

K65R frequently emerges within 1-6 weeks of tenofovir monotherapy in macaques

A genome armed against HIV

Circumcision: a surprising benefit from an unkind cut

Topical microbicides: the real front line of HIV prevention

Development of d-d4FC (dexelvucitabine, Reverset) discontinued

Lopinavir/r (meltrex) filed in South Africa

Indian community organisations file first opposition against patent application

ITPC Indian Mailbox database now online

Global fund review: timing of Round 6 still unclear

Knowledge about HIV transmission in the UK declined over last five years

Volunteer opportunity: improve healthcare for HIV-positive children in developing countries

Microbicides 2006 Conference, 23-26 April 2006, Cape Town, South Africa

HIV inSite Knowledge Base: new and updated chapters and lectures

Johns Hopkins pocket guide to HIV & AIDS treatment

Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy

Volume 7 Number 5 May 2006 PDF

Volume 7 Number 4 April 2006

Important renal safety information regarding the use of tenofovir and Truvada

HIV/HCV coinfection: re-treating hepatitis C in people coinfected with HIV

Further reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver

Pharmacokinetics of antiretrovirals in pregnancy: tenofovir, nelfinavir, lopinavir/r

Risk of central nervous system birth defects associated with ART exposure during pregnancy

No increase in adverse pregnancy outcomes in Thai women receiving nevirapine-containing HAART

ARV treatment following singe dose nevirapine exposure

Association of HIV replication capacity with mother to child transmission

Association between HIV subtype and detection of K103N

Pharmacology and drug interaction studies in adults: summary table from CROI, ICAAC and EACS conferences

Other new antiretrovirals at Denver: the future seems bright

Origins of HIV traced to chimpanzees in Cameroon

HSV-2 suppression reduces HIV and HSV shedding

NICE publishes TB guidelines in UK

WHO launches new stop TB strategy

Community responses to mainstream US magazine supporting HIV denialists

Online analysis of recent PK news

12th Annual BHIVA Conference abstracts

Full text journal publications online

Nelfinavir reduces pravastatin AUC by 46% in HIV negative volunteers

Treatment interuption arm in DART trial is stopped early

Treatment access new from Aidspan

China puts 23 HIV/AIDS patients under house arrest

Volume 7 Number 4 April 2006 PDF

TAC wins court case against Matthias Rath

13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver

Early integrase inhibitor studies in treatment experienced patients raise hopes for new drugs in a new class

Atazanavir in treatment naive patients, with and without ritonavir boosting

Simplification to atazanavir/ritonavir monotherapy

Summary of STI studies: SMART shows clear increased risk from interrupting treatment at any CD4 count

The effect of repeated single-dose nevirapine for PMTCT in a second pregnancy

Should criteria for initiation of HAART be revisited in pregnant women?

Cotrimoxazole prophylaxis in pregnancy

Treatment in primary HIV infection

CNS penetration of ARV drugs is associated with lower CSF viral load

Sexual transmission of hepatitis C in HIV-positive men in the UK

D:A:D study shows that PIs rather than NNRTIs drive the previously reported cardiovascular risk of combination antiretroviral therapy

Interventions for the management of lipodystrophy and metabolic complications

45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 16-19 December 2005, Washington, USA

One third of HIV/HCV coinfected patients with normal ALT have advanced fibrosis in Spanish cohort

Metrex formulation of Kaletra available on named patient access in UK

Treatment-naive trial of tipranavir discontinues highest dose arm

BMS licenses atazanavir to generic drug companies

Therapeutic vaccinations and treatment interruptions

Post navigation